Source: https://www.wileyrein.com/professionals-NealSeth.html
Timestamp: 2019-04-26 11:48:29+00:00

Document:
Neal is head of the firm’s Patent Practice and also serves on the Management Committee. He primarily focuses on patent litigation and appeals. He has handled cases covering a diverse spectrum of mechanical, chemical, and electrical technologies, with an emphasis on cases in the pharmaceutical industry.
Lead counsel for ANDA filer in litigation relating to Latuda (lurasidone), a treatment for schizophrenia. Sumitomo Dainippon Pharma Co., Ltd. et al. v. Aurobindo Pharma Ltd. et al., No. 2:18-cv-02620 (D.N.J. 2018).
Lead counsel for DJ plaintiff in litigation regarding sedative Precedex (dexmedetomidine hydrochloride). Baxter Healthcare Corporation v. Hospira, Inc. et al., No. 1:18-303 (D. Del. 2018).
Lead counsel for ANDA filer in litigation concerning antidepressant Trintellix (vortioxetine). Takeda Pharm. Co. Ltd. et al. v. Hetero USA Inc. et al., No. 1:18-cv-00176 (D. Del. 2018).
Lead counsel for plaintiff in litigation relating to Eligard (leuprolide acetate) indicated for prostate cancer. Horatio Washington Depot Technologies LLC v. Tolmar, Inc. et al., No. 1:17-cv-01086 (D. Del. 2017).
Lead counsel for ANDA filer in litigation relating to Xarelto (rivaroxaban), indicated to prevent and treat blood clots. Bayer Intellectual Property GmbH et al. v. Alembic Pharms. Ltd. et al., No. 1:17-cv-00675 (D. Del. 2017).
Lead counsel for ANDA filer in litigation relating to Eliquis (apixaban), indicated to prevent and treat blood clots. Bristol-Myers Squibb et al. v. Hetero USA Inc. et al., No. 1:17-cv-00376 (D. Del. 2017).
Lead counsel for petitioner in Case IPR 2016-01636 concerning Toviaz (fesoterodine).
Lead counsel for ANDA filer in litigation relating to Nexium OTC (esomeprazole), used for frequent heartburn. AstraZeneca et al., v. Hetero USA Inc. et al., No. 3:16-cv-02442 (D.N.J. 2016).
Lead counsel for petitioner in Case IPR 2016-00098 and IPR 2016-00111 relating to Treanda (bendamustine hydrochloride).
Lead counsel for ANDA filer in Hatch-Waxman litigation relating to Treanda (ready-to-dilute bendamustine hydrochloride), a cancer treatment. Cephalon v. Fresenius Kabi USA, LLC, 1:15-cv-00536 (D. Del. 2015).
Lead counsel for ANDA filer in litigation relating to Daliresp (roflumilast), indicated for chronic obstructive pulmonary disease. Takeda GMBH, et al. v. Hetero USA Inc., et al., No. 3:15-cv-03385 (D.N.J. 2015).
Lead counsel for ANDA filer in litigation relating to Abilify (aripiprazole). Otsuka Pharm. Co. Ltd. v. Torrent Pharms. et al., 1:14-cv-01078 and related cases (D.N.J. 2014).
Lead counsel for ANDA filer in Hatch-Waxman litigation relating to Treanda (lyophilized bendamustine hydrochloride), a cancer treatment. Cephalon v. Hetero Labs Ltd., 1:13-cv-02046 (D. Del. 2013).
Lead counsel for ANDA filer in litigation relating to Toviaz (fesoterodine), indicated for overactive bladder syndrome. Pfizer, Inc. and UCB Pharma GmbH v. Alkem Laboratories, Ltd., 1:13-cv-01110 (D. Del. 2013).
Lead counsel for the patent owner in ANDA litigation relating to Solaraze, indicated for actinic keratosis. Fougera Pharms., Inc. and Jagotec AG v. Tolmar, Inc., 1:10-cv-02635 (D. N.J. 2012).
Represented the patent owner in ANDA litigation upholding the validity of the patent covering Zyprexa (olanzapine), an atypical antipsychotic. Eli Lilly & Co. v. Zenith Goldline Pharms., Inc., 364 F. Supp. 2d 820 (S.D. Ind. 2005), affirmed by the Federal Circuit in 471 F.3d 1369 (Fed. Cir. 2006).
Represented appellants in the U.S. Court of Appeals for the Federal Circuit in successfully reversing the district court’s summary judgment of no infringement. 01 Communique Laboratory, Inc. v. LogMeIn, Inc., 687 F. 3d 1292 (Fed. Cir. 2012).
Lead counsel for the defendant accused of infringing patents relating to visual voicemail. Case settled favorably. Brandywine Communications Technologies, LLC v. LG Electronics, Inc., 6:12-cv-00271 (M.D. Fla. 2012).
Represented two respondents through trial in defending against allegations of patent infringement relating to three patents covering computer forensic devices. Prevailed on an Initial Determination finding no domestic industry. In the Matter of Certain Computer Forensic Devices and Products, No. 337-TA-799 (2012).
Represented complainant as lead counsel in a U.S. International Trade Commission patent infringement action relating to hand-held underground cable and pipe locators. The parties reached a global settlement during the investigation. In the Matter of Certain Underground Cable and Pipe Locators, No. 337-TA-727 (2010).
Lead counsel for defendants in a patent infringement litigation concerning robotic gripping fingers. GMG Gesellschaft Fur Modulare Greifersysteme mbH et al. v. Robotiq, Inc. et al., No. 2:16-cv-573 (E.D.Va. 2017).
Represented complainant in a patent infringement action relating to baby strollers and playards. Case settled favorably while summary determination motions were pending. In the Matter of Certain Strollers and Playards, Inv. No. 337-TA-762 (2011).
Argued and won a reversal of the Trademark Trial and Appeal Board’s (TTAB) canceling the mark at issue. Precedent-setting case confirmed that a mark’s prosecution file history is automatically of record in an inter partes board proceeding and clarified the burdens of proof in a validity-based trademark cancellation proceeding. The Cold War Museum Inc. v. Cold War Air Museum Inc., 586 F.3d 1352 (Fed. Cir. 2009).
Represented appellees in the U.S. Court of Appeals for the Federal Circuit’s affirming of the district court ruling on non-infringement and invalidity of patents covering aspects of wrinkle-free shirt seams. TALtech Ltd. v. Esquel Apparel, Inc., 279 Fed. Appx. 974 (Fed. Cir. 2008).
Represented respondents accused of infringing design patents covering aspects of the Ford F-150. In the Matter of Certain Automotive Parts, Inv. No. 337-TA-557 (2008).

References: v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v.